IGF-1 LR3

Peptoris Labs

IGF-1 LR3

Sold Out
£30.00

Plan your course

Not sure of the dose? Use the figure from this product's research protocol and choose whether it is per day or per week below.

Dose Frequency Course length

— vial(s) needed at — vial size

Estimate only — based on a steady dose at your chosen frequency and selected vial size. Titration may use less in early weeks. For research use only, not medical advice.

Description

IGF-1 LR3 is a synthetic 83-amino acid analog of human insulin-like growth factor-1 (IGF-1) that has been structurally modified to enhance its biological activity. The 'LR3' designation refers to two key modifications: an arginine substitution at position 3 (replacing glutamic acid) and a 13-amino acid N-terminal extension peptide. These modifications dramatically reduce binding to IGF binding proteins (IGFBPs), resulting in a significantly longer half-life and greater bioavailability compared to native IGF-1. In research settings, IGF-1 LR3 demonstrates approximately 2-3 times greater potency than native IGF-1 in stimulating cellular proliferation, making it a valuable tool for studying growth factor biology, muscle development, and metabolic regulation.

Certificate of Analysis

Every batch of IGF-1 LR3 is independently lab-tested to a minimum of 98% purity. A Certificate of Analysis is available on request — contact us with your order or lot number and we'll send the COA for your specific batch.

Request a COA

Research Protocol

Full dose-by-dose reconstitution & dosing protocol for IGF-1 LR3.

View Research Protocol →

For laboratory and scientific research use only. Not medical advice.

For laboratory and research use only. Minimum 98% purity. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.